Reaction of olefin derivatives in the presence of metathesis catalysts

文档序号:1077966 发布日期:2020-10-16 浏览:22次 中文

阅读说明:本技术 烯烃衍生物在复分解催化剂的存在下的反应 (Reaction of olefin derivatives in the presence of metathesis catalysts ) 是由 R·L·佩德尔森 A·M·约翰斯 于 2019-02-11 设计创作,主要内容包括:本发明提供了一种用于合成麝香大环化合物的方法,所述方法包括接触承载Z-烯烃部分的易于获得的二烯原料,并且在第8族烯烃复分解催化剂的存在下进行闭环复分解反应。<Image he="831" wi="673" file="DDA0002629549350000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>(The present invention provides a method for synthesizing musk macrocycles comprising contacting a readily available diene starting material bearing a Z-olefin moiety and conducting a ring closing metathesis reaction in the presence of a group 8 olefin metathesis catalyst.)

1. A process for the synthesis of a musk macrocyclic compound represented by formula (K)

The method comprises the following steps:

a) reacting an olefin represented by formula (G) in the presence of at least one group 8 metal olefin metathesis catalyst under conditions sufficient to form a metathesis product

Figure FDA0002629549330000012

With at least one metathesis reaction partner represented by formula (H),

wherein the at least one metathesis catalyst is represented by the structure of formula (4):

Figure FDA0002629549330000021

wherein:

R1mis H or methyl;

OR2mis a protected hydroxy group;

R3mc being branched or straight chain1-C5An alkyl group;

x is 2, 3,4 or 5;

y is 5, 6, 7 or 8;

m is a group 8 transition metal;

L2is a neutral electron donor ligand;

n is 0 or 1;

m is 0, 1 or 2;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

X1and X2Independently, an anionic ligand;

R1and R2Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; or R1And R2Linked together to form an optionally substituted indenylene group;

X5and Y5Independently C, CR3AOr N; and X5Or Y5Only one of them may be C or CR3A

R3AIs hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl;

q is a group having the structure- [ CR ]11R12]s-[CR13R14]t-or- [ CR11=CR13]A diatomic bond of (a);

R11、R12、R13and R14Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl;

"s" and "t" are independently 1 or 2;

R3is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; and is

R4Is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl.

2. The olefin metathesis catalyst of claim 1, wherein:

m is Ru;

n is 0;

m is 0;

Rais unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group;

Rbis unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

X1and X2Independently is halogen;

R1is hydrogen;

R2is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

X5and Y5Independently is N;

q is a group having the structure- [ CR ]11R12]s-[CR13R14]tA diatomic bond of (a);

R11、R12、R13and R14Independently is hydrogen;

"s" and "t" are independently 1;

R3is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; and is

R4Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide.

3. The olefin metathesis catalyst of claim 2, represented by the structure of formula (5),

Figure FDA0002629549330000041

wherein:

R1is hydrogen;

R2is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

Rais methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl or phenyl;

Rbis methyl, ethyl, n-butylPropyl, isopropyl, n-butyl, tert-butyl or phenyl; or RaAnd RbLinked together to form tetrahydrothiophene oxide having sulfoxide groups;

X1and X2Independently Cl, Br, F or I;

R3is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl or 2-methyl-phenyl; and is

R4Is 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl or 2-methyl-phenyl.

4. The olefin metathesis catalyst of claim 3 selected from the group consisting of:

5. the olefin metathesis catalyst of claim 1, wherein:

m is Ru;

n is 0;

m is 0;

Rais unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group;

Rbis unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

X1and X2Independently is halogen;

Figure FDA0002629549330000062

L1Is composed of

Figure FDA0002629549330000071

X3And X4Independently is S or O;

R1is hydrogen;

R2is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl;

X5and Y5Independently is N;

q is a group having the structure- [ CR ]11R12]s-[CR13R14]tA diatomic bond of (a);

R11、R12、R13and R14Independently is hydrogen;

"s" and "t" are independently 1;

R3is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, heteroaryl, and heteroaryl,Unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; and is

R4Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide.

6. The olefin metathesis catalyst of claim 5, represented by the structure of formula (8)

Wherein:

Rais methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

Rbis methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

R3is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 2, 6-difluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl or 2-methyl-phenyl;

R4is 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 2, 6-difluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl or 2-methyl-phenyl;

R1is hydrogen, and R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

R11is hydrogen or methyl, R12Is hydrogen or methyl, R13Is hydrogen, and R14Is hydrogen;

Rxis methyl, hydrogen or Cl; ryIs hydrogen; rwIs hydrogen; rzIs Cl, tert-butyl, hydrogen or phenyl; or RxAnd RyLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RwAnd RzLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RyAnd RwLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.

7. The olefin metathesis catalyst of claim 6 selected from the group consisting of:

8. a process for synthesizing a musk macrocyclic compound represented by formula (a):

the process comprises ring-closing metathesis of a diene of formula (E) in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product

Figure FDA0002629549330000101

Wherein:

Reis H, methyl, ethyl or propyl;

p is 1,2, 3 or 4;

q is 4,5, 6 or 7;

wherein the at least one metathesis catalyst is represented by the structure of formula (4):

wherein:

m is a group 8 transition metal;

L2is a neutral electron donor ligand;

n is 0 or 1;

m is 0, 1 or 2;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

X1and X2Independently, an anionic ligand;

R1and R2Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbonAn unsubstituted heteroatom-containing hydrocarbon group or a substituted heteroatom-containing hydrocarbon group; or R1And R2Linked together to form an optionally substituted indenylene group;

X5and Y5Independently C, CR3AOr N; and X5Or Y5Only one of them may be C or CR3A

R3AIs hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl;

q is a group having the structure- [ CR ]11R12]s-[CR13R14]t-or- [ CR11=CR13]A diatomic bond of (a);

R11、R12、R13and R14Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl;

"s" and "t" are independently 1 or 2;

R3is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; and is

R4Is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl.

9. The process of claim 8, wherein the olefin metathesis catalyst is represented by the structure of formula (5),

Figure FDA0002629549330000111

wherein:

R1is hydrogen;

R2is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

Rais methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl or phenyl;

Rbis methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl or phenyl; or RaAnd RbLinked together to form tetrahydrothiophene oxide having sulfoxide groups;

X1and X2Independently Cl, Br, F or I;

R3is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl or 2-methyl-phenyl; and is

R4Is 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl or 2-methyl-phenyl.

10. The process of claim 9, wherein the olefin metathesis catalyst is selected from the group consisting of:

Figure FDA0002629549330000122

11. the process of claim 8, wherein the olefin metathesis catalyst is represented by the structure of formula (8)

Wherein:

Rais methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

Rbis methyl,Ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

R3is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 2, 6-difluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl or 2-methyl-phenyl;

R4is 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 2, 6-difluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl or 2-methyl-phenyl;

R1is hydrogen, and R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

R11is hydrogen or methyl, R12Is hydrogen or methyl, R13Is hydrogen, and R14Is hydrogen;

Rxis methyl, hydrogen or Cl; ryIs hydrogen; rwIs hydrogen; rzIs Cl, tert-butyl, hydrogen or phenyl; or RxAnd RyLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RwAnd RzLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RyAnd RwLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.

12. The process of claim 11, wherein the olefin metathesis catalyst is selected from the group consisting of:

Figure FDA0002629549330000151

Background

Olefin metathesis has emerged as a valuable synthetic method for the formation of carbon-carbon double bonds since its discovery in the 50's of the 20 th century. Recent advances in organic synthesis and polymer synthesis applications have largely relied on the development of well-defined olefin metathesis catalysts.

Ruthenium metathesis catalyst technology has enabled the development of several research platforms, including: ring-opening metathesis polymerization (ROMP), ring-opening cross metathesis (ROCM), Cross Metathesis (CM), ring-closing metathesis (RCM).

In another embodiment, the present invention provides a method of synthesizing a macrocyclic compound for use in the fragrance industry.

The musk odour is probably the most widely recognised fragrance. Natural macrocyclic musk compounds are in fact ketones (of animal origin) and lactones (vegetable material). They are 15-membered ring systems or 17-membered ring systems. The type of odour is influenced by the size of the ring. Starting from 14 ring atoms, a slight musky smell is perceived. Compounds with 15-16 ring atoms exhibit a strong musky odour.

Macrocyclic musk compounds are expected to become increasingly important in the future, especially since many of them occur naturally and even synthetic representatives are highly similar to the natural counterparts. Furthermore, advances in synthetic chemistry have helped to reduce the price and will stimulate an increase in the use of such musk compounds.

Synthetic musk compounds can be divided into three main classes: aromatic nitro musk compounds, polycyclic musk compounds and macrocyclic musk compounds. Thus, macrocyclic musk compounds have gained increasing importance in recent years.

The synthesis of macrocyclic musk compounds is difficult and in many cases a multistep process. The economic significance of such compounds is still very limited due to the relatively high production costs. However, there is a great need in the perfume industry for a stable variety of these musk compounds.

There is a need for efficient processes for the preparation of cyclic compounds based on intermediate rings and especially on macrocycles having at least one keto group. The intermediate ring typically has 8 to 11 carbon atoms, rings higher than 12 carbon atoms are referred to as macrocycles, and macrocycle-based compounds are also referred to as macrocycles. Macrocyclic ketones, lactones and epoxides, as well as other functionalized macrocyclic compounds, are valuable fragrance chemicals in the fragrance industry. There is a need to create new synthetic routes for macrocyclic musk compounds of high value and value.

The present invention solves the problems of the prior art and provides for the efficient and high yield synthesis of macrocyclic musk compounds and their open-chain intermediates using cross-metathesis in the presence of a group 8 metal olefin metathesis catalyst.

The stereochemistry of olefins (E or Z) in these cyclic structures is often crucial for the biological activity of the molecule or its olfactory properties, and small amounts of impurities of other stereoisomers in chemical mixtures can significantly reduce their potency. It is particularly difficult to separate the E-and Z-isomers because their separation techniques are not general. Therefore, the process for producing stereochemically pure cyclic compounds is of crucial importance.

Controlling the olefin stereochemistry in RCM reactions can be difficult. When using common non-selective metathesis catalysts, selectivity is governed by the thermodynamic stability of the olefin product and can vary depending on the ring size and the position of the double bond.

In addition, macrocyclization reactions using RCM typically require high catalyst loadings. In these cases, removal of residual metals, the presence of which in the final product may be undesirable or potentially isomerize the product, may be difficult. For some applications, this requires further purification using additives or multiple chromatography columns, followed by treatment with charcoal.

Common macrocyclic musk compounds include musk lactones (9-and 7-musk lactones), norvalactone (nirvanolide), cyclopentadecenolide, melonic musk, musk ketene, cyclohexadecenone (velvione), dihydrocivetone, cyclopentadecanone, civetone and cyclohexadecenone (globanone).

The present invention provides a process for forming a macrocyclic musk compound, comprising the steps of: a first olefin and a second olefin are cross-metathesized in the presence of at least one group 8 metal olefin metathesis catalyst to form a cross-metathesis product, which is then cyclized to form the desired macrocyclic musk compound.

The macrocyclic musk compounds may be formed by ring-closing metathesis of dienes in the presence of at least one group 8 metal olefin metathesis catalyst. More particularly, the present invention relates to novel methods for obtaining musk macrocyclic compounds of the Z configuration via cross-metathesis reactions in the presence of at least one group 8 metal Z-stereoretentive olefin metathesis catalyst.

With the readily available diene feedstock carrying the Z-olefin moiety, the macrocyclization reaction produces products with significantly higher Z-selectivities with significantly shorter reaction times, higher yields and much lower catalyst loadings than previously reported systems. Macrolides ranging in size from twelve to seventeen membered rings with excellent Z-selectivity (95% - > 99% Z) were synthesized in moderate to high yields (68% -79% yield).

Disclosure of Invention

Macrocyclic compounds of musk

The present invention relates to a process for the preparation of cyclic compounds having at least eight carbon atoms and at least one keto group for use in the fragrance industry, comprising performing ring-closing metathesis in the presence of at least one group 8 metal olefin metathesis catalyst.

Ring-closing metathesis reactions are achieved using the catalysts of the present invention and have been shown to occur on a variety of substrates. The reaction was completed in dichloromethane at 40 ℃ under static vacuum (30mTorr) in 1 hour using a standard catalyst loading of 6 mole% typically used in macrocyclization reactions. Twelve-to seventeen-membered rings were synthesized all at high Z-selectivity (95% -99% Z) in moderate to high yields (68% -79% isolated yield). Yuzu lactone (Z) -oxacyclotridec-10-en-2-one is highly desirable for the fragrance industry and can be synthesized using ruthenium olefin metathesis catalysts more rapidly and selectively than previously reported. Larger macrolides (pentadecenyl to heptadecenyl) are synthesized in slightly higher yields than the smaller twelve to fourteen ring macrolides.

In summary, highly active ruthenium-based olefin metathesis catalysts are used to generate high-height Z-macrocycles (95% to 99% Z) from readily available diene substrates having Z-olefin moieties.

In another aspect, the macrocyclic musk compounds may be synthesized via ring-closing olefin metathesis of diolefins in the presence of at least one group 8 metal olefin metathesis catalyst.

In another embodiment, the ring-closing metathesis reaction product has a carbon-carbon double bond in the Z-configuration and is represented by the structure of formula (A):

wherein:

q is 1,2, 3, or 4; and

p is 4,5, 6 or 7.

In another embodiment, the ring-closing metathesis reaction product has a carbon-carbon double bond in the Z-configuration and is represented by the structure of formula (B):

wherein:

r is 1,2, 3 or 4; and

v is 4,5, 6 or 7.

In another embodiment, the ring-closing metathesis reaction product has a carbon-carbon double bond in the Z-configuration and is represented by the structure of formula (C):

wherein:

qcis 1,2, 3 or 4; and

pcis 4,5, 6 or 7.

In another embodiment, the ring-closing metathesis reaction product has a carbon-carbon double bond and is represented by the structure of formula (K):

Figure BDA0002629549340000051

wherein:

x is 2, 3,4 or 5;

y is 5, 6, 7 or 8.

In another aspect, the present invention provides a method of forming a macrocyclic musk compound, the method comprising the steps of: cross-metathesizing a first olefin and a second olefin in the presence of at least one group 8 metal olefin metathesis catalyst to form an intermediate of the first olefin and the second olefin, and cyclizing the intermediate to form a macrocyclic musk compound.

These and other aspects of the invention will be apparent to those skilled in the art from the following detailed description and examples. Furthermore, it should be understood that neither the embodiments nor examples of the invention described herein are to be construed as limiting.

Detailed Description

Unless otherwise specified, the invention is not limited to particular reactants, substituents, catalysts, reaction conditions, etc., as they may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting.

As used in the specification and the appended claims, the singular forms "a", "an", and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "an olefin" includes a single olefin as well as a combination or mixture of two or more olefins, reference to "a substituent" encompasses a single substituent as well as two or more substituents and the like.

As used in the specification and the appended claims, the terms "for example", "for instance", "such as" or "including" are intended to introduce examples that further illustrate more general subject matter. Unless otherwise indicated, these examples are provided solely to aid in the understanding of the present invention and are not meant to be limiting in any way.

In this specification and in the claims which follow, reference will be made to a number of terms which shall be defined to have the following meanings:

as used herein, the term "alkyl" generally refers to a straight, branched, or cyclic saturated hydrocarbon group, but not necessarily containing 1 to 30 carbon atoms, typically containing 1 to 24 carbon atoms, typically 1 to 12 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, octyl, decyl, and the like, as well as cycloalkyl groups such as cyclopentyl, cyclohexyl, and the like. The term "lower alkyl" refers to an alkyl group having 1 to 6 carbon atoms, and the specific term "cycloalkyl" refers to a cyclic alkyl group typically having 3 to 12, or 4 to 12, or 3 to 10, or 3 to 8 carbon atoms. The term "substituted alkyl" refers to an alkyl group substituted with one or more substituent groups, and the terms "heteroatom-containing alkyl" and "heteroalkyl" refer to an alkyl group in which at least one carbon atom is replaced with a heteroatom. The terms "alkyl" and "lower alkyl" if not otherwise indicated include straight-chain, branched-chain, cyclic, unsubstituted, substituted and/or heteroatom-containing alkyl and lower alkyl, respectively.

As used herein, the term "alkylene" refers to a divalent straight, branched, or cyclic alkyl group, wherein "alkyl" is as defined herein.

As used herein, the term "alkenyl" refers to a straight, branched, or cyclic hydrocarbon group having 2 to 30 carbon atoms containing at least one double bond, such as ethenyl, n-propenyl, iso-propenyl, n-butenyl, iso-butenyl, octenyl, decenyl, tetradecenyl, hexadecenyl, eicosenyl, tetracenyl, and the like. Generally, an "alkenyl" group herein contains 2 to 24 carbon atoms, and typically an "alkenyl" group herein contains 2 to 12 carbon atoms. The term "lower alkenyl" refers to an "alkenyl" group having 2 to 6 carbon atoms, and the particular term "cycloalkenyl" refers to a cyclic "alkenyl" group typically having 5 to 8 carbon atoms. The term "substituted alkenyl" refers to "alkenyl" substituted with one or more substituent groups, and the terms "heteroatom-containing alkenyl" and "heteroalkenyl" refer to "alkenyl" in which at least one carbon atom is replaced with a heteroatom. The terms "alkenyl" and "lower alkenyl", if not otherwise indicated, include straight-chain, branched-chain, cyclic, unsubstituted, substituted and/or heteroatom-containing "alkenyl" and lower "alkenyl", respectively. The term "alkenyl" is used interchangeably with the term "alkene" herein.

As used herein, the term "alkenylene" refers to a divalent straight, branched, or cyclic alkenyl group, wherein "alkenyl" is as defined herein.

As used herein, the term "alkynyl" refers to a straight or branched chain hydrocarbon group having 2 to 30 carbon atoms containing at least one triple bond, such as ethynyl, n-propynyl, and the like. Generally, an "alkynyl" group herein contains 2 to 24 carbon atoms; typically, an "alkynyl" group as described herein contains from 2 to 12 carbon atoms. The term "lower alkynyl" refers to an "alkynyl" group having 2 to 6 carbon atoms. The term "substituted alkynyl" refers to "alkynyl" substituted with one or more substituent groups, and the terms "heteroatom-containing alkynyl" and "heteroalkynyl" refer to "alkynyl" in which at least one carbon atom is replaced with a heteroatom. The terms "alkynyl" and "lower alkynyl" include straight-chain, branched-chain, unsubstituted, substituted and/or heteroatom-containing "alkynyl" and lower "alkynyl", respectively, if not otherwise indicated.

As used herein, the term "alkoxy" refers to an alkyl group bonded through a single terminal ether linkage; that is, an "alkoxy" group can be represented as-O-alkyl, where alkyl is as defined herein. "lower alkoxy" group refers to an alkoxy group containing 1 to 6 carbon atoms. Similarly, "alkenyloxy" and "lower alkenyloxy" refer to alkenyl and lower alkenyl groups, respectively, bonded through a single terminal ether linkage, and "alkynyloxy" and "lower alkynyloxy" refer to alkynyl and lower alkynyl groups, respectively, bonded through a single terminal ether linkage.

As used herein, and unless otherwise indicated, the term "aryl" refers to an aromatic substituent containing a single aromatic ring or multiple aromatic rings that are fused together, directly linked, or indirectly linked (such that different aromatic rings are bonded to a common group such as a methylene or ethylene moiety). An "aryl" group contains 5 to 30 carbon atoms, typically an "aryl" group contains 5 to 20 carbon atoms; and typically, an "aryl" group contains 5 to 14 carbon atoms. Exemplary "aryl" groups contain one aromatic ring or two fused or linked aromatic rings, such as phenyl, naphthyl, biphenyl, diphenyl ether, diphenylamine, benzophenone, and the like. "substituted aryl" refers to an aryl moiety substituted with one or more substituent groups; for example, 2,4, 6-trimethylphenyl (i.e., mesityl or Mes), 2-methyl-phenyl, 2, 6-di-isopropylphenyl (i.e., DIPP or DIPP), 2-isopropyl-phenyl (i.e., IPP or IPP), 2-isopropyl-6-methylphenyl (i.e., MIPP or MIPP). The terms "heteroatom-containing aryl" and "heteroaryl" refer to an "aryl" substituent in which at least one carbon atom is replaced with a heteroatom, as will be described in further detail below.

As used herein, the term "aryloxy" refers to an aryl group bonded through a single terminal ether linkage, wherein "aryl" is as defined herein. An "aryloxy" group can be represented as-O-aryl, where aryl is as defined herein. Preferred "aryloxy" groups contain 5 to 24 carbon atoms, and particularly preferred "aryloxy" groups contain 5 to 14 carbon atoms. Examples of "aryloxy" groups include, but are not limited to, phenoxy, o-halo-phenoxy, m-halo-phenoxy, p-halo-phenoxy, o-methoxy-phenoxy, m-methoxy-phenoxy, p-methoxy-phenoxy, 2, 4-dimethoxy-phenoxy, 3,4, 5-trimethoxy-phenoxy, and the like.

The term "alkaryl" refers to an aryl group having an alkyl substituent, and the term "aralkyl" refers to an alkyl group having an aryl substituent, wherein "aryl" and "alkyl" are defined herein. The "alkaryl" and "aralkyl" groups contain from 6 to 30 carbon atoms; generally, "alkaryl" and "aralkyl" groups contain from 6 to 20 carbon atoms; and generally, "alkaryl" and "aralkyl" groups contain from 6 to 16 carbon atoms. "alkaryl" groups include, for example, p-methylphenyl, 2, 4-dimethylphenyl, p-cyclohexylphenyl, 2, 7-dimethylnaphthyl, 7-cyclooctylphenyl, 3-ethyl-cyclopenta-1, 4-diene, and the like. Examples of "aralkyl" groups include, but are not limited to, benzyl, 2-phenyl-ethyl, 3-phenyl-propyl, 4-phenyl-butyl, 5-phenyl-pentyl, 4-phenylcyclohexyl, 4-benzylcyclohexyl, 4-phenylcyclohexylmethyl, 4-benzylcyclohexylmethyl, and the like. The terms "alkylaryloxy" and "aralkyloxy" refer to a substituent of the formula — OR, wherein R is "alkylaryl" OR "arylalkyl," respectively, as defined herein.

The term "acyl" refers to a substituent having the formula- (CO) -alkyl, - (CO) -aryl, or- (CO) -aralkyl, and the term "acyloxy" refers to a substituent having the formula-O (CO) -alkyl, -O (CO) -aryl, or-O (CO) -aralkyl, wherein "alkyl", "aryl", and "aralkyl" are as defined herein.

The terms "cyclic" and "ring" refer to an alicyclic or aromatic group, which may or may not be substituted and/or contain heteroatoms, and which may be monocyclic, bicyclic, or polycyclic. The term "cycloaliphatic," as used in the conventional sense, refers to an aliphatic cyclic moiety, as opposed to an aromatic cyclic moiety, which may be monocyclic, bicyclic, or polycyclic.

The terms "halo", "halogen" and "halide" are used in their conventional sense to refer to chloro, bromo, fluoro or iodo substituents.

The term "hydrocarbyl" refers to a monovalent "hydrocarbyl" moiety containing 1 to 30 carbon atoms, typically 1 to 24 carbon atoms, specifically 1 to 12 carbon atoms, and includes straight, branched, cyclic, saturated, and unsaturated species such as alkyl groups, alkenyl groups, aryl groups, and the like. The term "lower hydrocarbyl" refers to "hydrocarbyl" groups having 1 to 6 carbon atoms, typically 1 to 4 carbon atoms, and the term "hydrocarbylene" refers to a divalent "hydrocarbyl" moiety containing 1 to 30 carbon atoms, typically 1 to 24 carbon atoms, specifically 1 to 12 carbon atoms, including straight, branched, cyclic, saturated and unsaturated species. The term "lower hydrocarbylene" refers to a "hydrocarbylene" group having from 1 to 6 carbon atoms. "substituted hydrocarbyl" refers to "hydrocarbyl" substituted with one or more substituent groups, and the terms "heteroatom-containing hydrocarbyl" and "heterohydrocarbyl" refer to hydrocarbyl in which at least one carbon atom is replaced with a heteroatom. Similarly, "substituted hydrocarbylene" refers to "hydrocarbylene" substituted with one or more substituent groups, and the terms "heteroatom-containing hydrocarbylene" and "heterohydrocarbylene" refer to "hydrocarbylene" in which at least one carbon atom is replaced with a heteroatom. Unless otherwise indicated, the terms "hydrocarbyl" and "hydrocarbylene" will be understood to include substituted and/or heteroatom-containing "hydrocarbyl" and "hydrocarbylene" moieties, respectively.

The term "heteroatom-containing" as in "heteroatom-containing hydrocarbyl group" refers to a hydrocarbon molecule or a fragment of a hydrocarbyl molecule in which one or more carbon atoms are replaced by an atom other than carbon, such as nitrogen, oxygen, sulfur, phosphorus, or silicon, typically nitrogen, oxygen, or sulfur. Similarly, the term "heteroalkyl" refers to a heteroatom-containing alkyl substituent, the term "heterocycle" refers to a heteroatom-containing cyclic substituent, and the terms "heteroaryl" and "heteroaromatic" refer to a heteroatom-containing "aryl" and "aromatic" substituent, respectively, and the like. It should be noted that the "heterocyclic" group or compound may or may not be aromatic, and it should also be noted that the "heterocyclic" may be monocyclic, bicyclic, or polycyclic, as described above with respect to the term "aryl". Examples of heteroaryl groups include alkoxyaryl, alkylsulfanyl-substituted alkyl, N-alkylated aminoalkyl, and the like. Examples of heteroaryl substituents include pyrrolyl, pyrrolidinyl, pyridyl, quinolinyl, indolyl, pyrimidinyl, imidazolyl, 1,2, 4-triazolyl, tetrazolyl, and the like.

By "substituted" as in "substituted hydrocarbyl", "substituted alkyl", "substituted aryl", and the like, as incidentally mentioned in some of the foregoing definitions, it is meant that in the hydrocarbyl, alkyl, aryl, or other moiety, at least one hydrogen atom bonded to a carbon (or other) atom is replaced with one or more non-hydrogen substituents. Examples of such substituents include, but are not limited to: functional groups referred to herein as "Fn", such as halo, hydroxy, mercapto, C1-C24Alkoxy radical, C2-C24Alkenyloxy radical, C2-C24Alkynyloxy, C5-C24Aryloxy radical, C6-C24Aralkyloxy radical, C6-C24Alkaryloxy, acyl (including C)2-C24Alkylcarbonyl (-CO-alkyl) and C6-C24Arylcarbonyl (-CO-aryl)), acyloxy (-O-acyl, including C)2-C24Alkylcarbonyloxy (-O-CO-alkyl) and C6-C24Arylcarbonyloxy (-O-CO-aryl)), C2-C24Alkoxycarbonyl (- (CO) -O-alkyl), C6-C24Aryloxycarbonyl (- (CO) -O-aryl), halocarbonyl (- (CO) -X wherein X is halo), C2-C24Alkylcarbonate (-O- (CO) -O-alkyl), C6-C24Arylcarbonate (-O- (CO) -O-aryl), carboxyl (-COOH), carboxylate (-COO)-) Carbamoyl (- (CO) -NH)2) Mono- (C)1-C24Alkyl) -substituted carbamoyl (- (CO) -NH (C)1-C24Alkyl)), di- (C)1-C24Alkyl) -substituted carbamoyl (- (CO) -N (C)1-C24Alkyl radical)2) Mono- (C)5-C24Aryl) -substituted carbamoyl (- (CO) -NH-aryl), di- (C)5-C24Aryl) -substituted carbamoyl (- (CO) -N (C)5-C24Aryl radical)2) Thiocarbamoyl (- (CS) -NH)2) Mono- (C)1-C24Alkyl) -substituted thiocarbamoyl (- (CS) -NH (C)1-C24Alkyl)), di- (C)1-C24Alkyl) -substituted thiocarbamoyl (- (CS) -N (C)1-C24Alkyl radical)2) Mono- (C)5-C24Aryl) -substituted thiocarbamoyl (- (CS) -NH-aryl), bis- (C)5-C24Aryl) -substituted thiocarbamoyl (- (CS) -N (C)5-C24Aryl radical)2) Ureido (-NH- (CO) -NH)2) Cyano (-C.ident.N), cyanato (-O-C.ident.N), thiocyanate (-S-C.ident.N), formyl (- (CO) -H), thiocarbonyl (- (CS) -H), amino (-NH-H)2) Mono- (C)1-C24Alkyl) -substituted amino, di- (C)1-C24Alkyl) -substituted amino, mono- (C)5-C24Aryl) -substituted amino, di- (C)5-C24Aryl) -substitutedAmino group(s), (C)1-C24Alkyl) (C5-C24Aryl) -substituted amino, (C)2-C24Alkyl) -amido (-NH- (CO) -alkyl), (C)6-C24Aryl) -amido (-NH- (CO) -aryl), imino (-CR ═ NH, where R is hydrogen, C1-C24Alkyl radical, C5-C24Aryl radical, C6-C24Alkylaryl group, C6-C24Aralkyl, etc.), (C2-C20Alkyl) -imino (-CR ═ N (alkyl), where R is hydrogen, C1-C24Alkyl radical, C5-C24Aryl radical, C6-C24Alkylaryl group, C6-C24Aralkyl, etc.), arylimino (-CR ═ N (aryl), where R is hydrogen, C1-C20Alkyl radical, C5-C24Aryl radical, C6-C24Alkylaryl group, C6-C24Aralkyl, etc.), nitro (-NO)2) Nitroso group (-NO), sulfo group (-SO)2-OH), sulfonate (-SO)2-O-)、(C1-C24Alkyl) -sulfanyl (-S-alkyl; also referred to as "alkylthio"), (C)5-C24Aryl) -sulfanyl (-S-aryl; also known as "arylthio"), (C)1-C24Alkyl-sulfinyl (- (SO) -alkyl), (C)5-C24Aryl-sulfinyl (- (SO) -aryl), (C)1-C24Alkyl) -sulfonyl (-SO2Alkyl), mono- (C)1-C24Alkyl) -aminosulfonyl (-SO2-N (H) alkyl), di- (C)1-C24Alkyl) -aminosulfonyl (-SO2-N (alkyl)2)、(C5-C24Aryl) -sulfonyl (-SO)2Aryl), boron (-BH)2) Boron-dioxy (-B (OH)2) Boronato (boronato) (-B (OR))2Wherein R is alkyl or other hydrocarbyl group, phosphono (-P (O) (OH)2) Phosphonoxy (-P (O) (-) (O))-)2) Phosphinic acid ester group (phosphinato) (-P (O) (-O)-) Phosphorus oxide (-PO), phosphorus oxide2) And phosphino (-PH)2) (ii) a And a hydrocarbyl moiety C1-C24Alkyl (preferably C)1-C12Alkyl, more preferably C1-C6Alkyl group), C2-C24Alkenyl (preferably C)2-C12Alkenyl, more preferably C2-C6Alkenyl), C2-C24Alkynyl (preferably C)2-C12Alkynyl, more preferably C2-C6Alkynyl), C5-C24Aryl (preferably C)5-C14Aryl group), C6-C24Alkylaryl (preferably C)6-C16Alkaryl), and C6-C24Aralkyl (preferably C)6-C16Aralkyl).

The term "NHC" ligand refers to an N-heterocyclic carbene ligand.

The term "CAAC" ligand refers to a cyclic alkylamino carbene ligand, also known as a "Bertrand-type ligand".

Functional groups such as ethers, esters, hydroxyl, carbonates may be protected in cases where the functional group interferes with the olefin metathesis catalyst, and any of the protecting groups commonly used in the art may be employed. Acceptable protecting Groups can be found, for example, in Greene et al, Protective Groups in Organic Synthesis, 4 th edition (published by John Wiley & Sons, Inc., Hobock, N.J., 2007).

The olefin geometry described in this application may have an E-configuration, or a Z-configuration, or a mixture of E-and Z-configurations. Applicant has achieved through the use of wave-shaped keysRepresents a mixture of double bond isomers. For example, as represented herein, a structureIllustrating the E-configuration

Figure BDA0002629549340000113

Or in the Z-configuration

Figure BDA0002629549340000114

OrMay represent a mixture of E-configuration and Z-configuration. Suitable ether protecting groups include branched or unbranched alkyl moieties containing from 1 to 5 carbon atoms, such as methyl, ethyl, propyl, isopropyl, tert-butyl or tert-pentyl.

Suitable ester protecting groups include-c (o) R (where R ═ hydrogen) or branched or unbranched alkyl moieties containing 1 to 7 carbon atoms, such as methyl, ethyl, propyl, isopropyl, tert-butyl or tert-pentyl.

Suitable silyl ether protecting groups include-Si (R)3(ii) a Where R is a branched or unbranched alkyl moiety, which may include methyl, ethyl, propyl and tert-butyl.

Suitable carbonate protecting groups include-C (O) OR, where R is a branched OR unbranched alkyl moiety, such as methyl, ethyl, OR propyl.

By "sulfoxide group" is meant- [ S (O) ] -.

By "functionalized" as in "functionalized hydrocarbyl," "functionalized alkyl," "functionalized olefin," "functionalized cyclic olefin," and the like, is meant that in the hydrocarbyl, alkyl, olefin, cyclic olefin, or other moiety, at least one hydrogen atom bonded to a carbon (or other) atom is replaced with one or more functional groups such as those described above. The term "functional group" is meant to include any functional material suitable for the purposes described herein. In particular, as used herein, a functional group must have the ability to react or bond with a corresponding functional group on the surface of a substrate.

In addition, if permitted by a particular functional group, the functional group can be further substituted with one or more additional functional groups or one or more hydrocarbyl moieties such as those specifically enumerated herein. Similarly, the hydrocarbyl moieties described herein may be further substituted with one or more functional groups or additional hydrocarbyl moieties such as those specifically enumerated.

"optional" or "optionally" means that the subsequently described circumstance may or may not occur, such that the description includes instances where the circumstance occurs and instances where it does not. For example, the phrase "optionally substituted" means that a non-hydrogen substituent may or may not be present on a given atom, and thus, the description includes structures wherein a non-hydrogen substituent is present and structures wherein a non-hydrogen substituent is not present.

Group 8 metal olefin metathesis catalysts

The group 8 metal olefin metathesis catalyst of the invention is represented by the general structure of formula (1)

Figure BDA0002629549340000121

Wherein:

m is a group 8 transition metal; typically, M is ruthenium or osmium; typically, M is ruthenium;

L1and L2Independently a neutral electron donor ligand;

n is 0 or 1; typically, n is 0;

m is 0, 1 or 2; typically, m is 0;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RaIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RaIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RbIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RbIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexylOr phenyl; or RaAnd RbAre linked together to form a polymer having a sulfoxide group [ -S (O) -]A five-or six-membered heterocyclic ring of (a);

X1and X2Independently, an anionic ligand; generally, X1And X2Independently halogen, trifluoroacetate, perfluorophenol or nitrate; in general, X1And X2Independently Cl, Br, I or F; and is

R1And R2Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R1Is hydrogen, and R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene.

In some embodiments of formula (1),

is composed of

Figure BDA0002629549340000132

Wherein:

M、X1and X2As defined herein;

X3and X4Independently is O or S; and is

Rx、Ry、RwAnd RzIndependently hydrogen, halogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or RxAnd RyLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RwAnd RzLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RyAnd RwLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.

The group 8 metal olefin metathesis catalyst used in the present invention may be represented by the structure of formula (2):

wherein:

m is a group 8 transition metal; typically, M is ruthenium or osmium; typically, M is ruthenium;

L1and L2Independently a neutral electron donor ligand;

n is 0 or 1; typically, n is 0;

m is 0, 1 or 2; typically, m is 0;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RaIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RaIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RbIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RbIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

R1and R2Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heterolepticAn atomic hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R1Is hydrogen, and R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

X3and X4Independently is O or S; in general, X3And X4Independently is S; and

Rx、Ry、Rwand RzIndependently hydrogen, halogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; in general, Rx、Ry、RwAnd RzIndependently hydrogen, halogen, unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, Rx、Ry、RwAnd RzIndependently is C1-C6Alkyl, hydrogen, unsubstituted phenyl, substituted phenyl or halogen; or RxAnd RyLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RwAnd RzLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RyAnd RwLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.

The group 8 metal olefin metathesis catalyst used in the present invention is represented by the structure of formula (3),

wherein:

m is a group 8 transition metal; typically, M is ruthenium or osmium; typically, M is ruthenium;

L2is a neutral electron donor ligand;

n is 0 or 1; typically, n is 0;

m is 0, 1 or 2; typically, m is 0;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RaIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RaIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RbIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RbIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

X1and X2Independently, an anionic ligand; generally, X1And X2Independently halogen, trifluoroacetate, perfluorophenol or nitrate; in general, X1And X2Independently Cl, Br, I or F;

R1and R2Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R1Is hydrogen, and R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

X5and Y5Independently C, CR3AN, O, S or P; x5Or Y5Only one of them may be C or CR3A(ii) a In general, X5And Y5Independently is N;

Q1、Q2、R3、R3Aand R4Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; generally speaking, Q1、Q2、R3、R3AAnd R4Is optionally attached to X via a linking group such as unsubstituted hydrocarbylene, substituted hydrocarbylene, unsubstituted heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, or- (CO) -5Or Y5(ii) a Generally, Q1、Q2、R3、R3AAnd R4Directly connected to X5Or Y5(ii) a And is

When X is present5When is O or S, p is 0; when X is present5Is N, P or CR3AWhen p is 1; and when X5When is C, p is 2; when Y is5Q is 0 when O or S is contained; when Y is5Is N, P or CR3AWhen q is 1; and when X5When it is C, q is 2.

The group 8 metal olefin metathesis catalyst used in the present invention is represented by the structure of formula (4):

wherein:

m is a group 8 transition metal; typically, M is ruthenium or osmium; typically, M is ruthenium;

n is 0 or 1; typically, n is 0;

m is 0, 1 or 2; typically, m is 0;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substitutedA heteroatom-containing hydrocarbon group; in general, RaIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RaIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RbIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RbIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

X1and X2Independently, an anionic ligand; generally, X1And X2Independently halogen, trifluoroacetate, perfluorophenol or nitrate; in general, X1And X2Independently Cl, Br, I or F;

R1and R2Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R1Is hydrogen, and R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

X5and Y5Independently C, CR3AOr N; x5Or Y5Only one of them may be C or CR3A(ii) a In general, X5And Y5Independently is N;

R3Ais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl;

q is a linking group, typically unsubstituted hydrocarbylene, substituted hydrocarbylene, unsubstituted heteroatom-containing hydrocarbylene, or substituted heteroatom-containing hydrocarbylene; generally, Q is a compound having the structure- [ CR ]11R12]s-[CR13R14]t-or- [ CR11=CR13]A diatomic bond of (a); typically, Q is- [ CR ]11R12]s-[CR13R14]t-, wherein R11、R12、R13And R14Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R11、R12、R13And R14Independently hydrogen, unsubstituted C1-C12Alkyl, substituted C1-C12Alkyl, unsubstituted C1-C12Heteroalkyl, substituted C1-C12Heteroalkyl, unsubstituted C5-C14Aryl or substituted C5-C14An aryl group;

"s" and "t" are independently 1 or 2; typically, "s" and "t" are independently 1; or R11、R12、R13And R14Optionally joined together to form a substituted or unsubstituted, saturated or unsaturated ring structure;

R3is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R3Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted (C)5-C24Aryl), substituted with up to three substituents selected from the group consisting of5-C24Aryl): unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R3Is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl, 2, 6-difluorophenyl, 2-fluoro-6-methylphenyl or 2-methyl-phenyl; and is

R4Is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R4Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted (C)5-C24Aryl) or (C) substituted by up to three substituents selected from5-C24Aryl): unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R4Is 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-iso-propylPropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl, 2, 6-difluorophenyl, 2-fluoro-6-methylphenyl or 2-methyl-phenyl; or when X is5Is CR3AWhen R is3AAnd R4May form, together with the carbon atom to which they are attached, a five-to ten-membered cycloalkyl or heterocyclic ring.

In some embodiments of formula (4),

is composed of

Figure BDA0002629549340000182

Wherein: x1、X2、X3、X4、M、Rx、Ry、RwAnd RzAs defined herein.

When Q is- [ CR ]11R12]s-[CR13R14]t-, s is 1, t is 1, and R is11、R12、R13And R14Independently hydrogen, and M is ruthenium, the olefin metathesis catalyst of formula (4) is represented by the structure of formula (5)

Figure BDA0002629549340000191

Wherein:

R1is hydrogen;

R2is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RaIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RaIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RbIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RbIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group; in general, RaAnd RbLinked together to form tetrahydrothiophene oxide;

X1and X2Independently halogen, trifluoroacetate, perfluorophenol or nitrate; generally, X1And X2Independently Cl, Br, I or F; in general, X1And X2Independently is Cl;

R3is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R3Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl, C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstitutedC of (A)5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R3Is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl or 2-methyl-phenyl; and is

R4Is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R4Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R4Is 2,4, 6-trimethylphenyl, 2-isopropyl-phenyl, 2, 6-diisopropylphenyl, 2-isopropyl-6-methylphenyl or 2-methyl-phenyl.

Non-limiting examples of olefin metathesis catalysts represented by the structure of formula (5) are described in Table (1), where X1Is Cl, and X2Is Cl.

Table (1): an olefin metathesis catalyst of formula (5)

Figure BDA0002629549340000221

Figure BDA0002629549340000251

Wherein: mes isMipp is

Figure BDA0002629549340000253

DIPP isAdamantyl isIPP is2-Me-C6H5Is composed ofMe is CH3-, n-Bu is [ CH3-(CH2)3-]Ph is

Figure BDA0002629549340000258

And isIs [ - (CH)2)4-]。

When Q is of the structure- [ CR ]11=CR13]A diatomic bond of (A) and R11And R13When M is ruthenium and hydrogen, the olefin metathesis catalyst of formula (4) is represented by the structure of formula (6)

Wherein:

R1is hydrogen;

R2is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; raIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; rbIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

X1and X2Independently halogen, trifluoroacetate, perfluorophenol or nitrate; x1And X2Independently Cl, Br, I or F; in general, X1And X2Independently is Cl;

R3is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R3Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl, C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R3Is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl or 2-methyl-phenyl; and is

R4Is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R4Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R4Is 2,4, 6-trimethylphenyl, 2-isopropyl-phenyl, 2, 6-diisopropylphenyl, 2-isopropyl-6-methylphenyl or 2-methyl-phenyl.

Non-limiting examples of olefin metathesis catalysts represented by the structure of formula (6) are described in table (2), where X1Is Cl, and X2Is Cl.

Table (2): an olefin metathesis catalyst of formula (6)

Figure BDA0002629549340000271

Figure BDA0002629549340000301

When Y is N, X5Is CR3AAnd M is ruthenium, the olefin metathesis catalyst of formula (4) is represented by the structure of formula (7)

Figure BDA0002629549340000321

Wherein:

R1is hydrogen;

R2is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

Rais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RaIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RaIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl;

Rbis hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RbIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RbIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

X1and X2Independently halogen, trifluoroacetate, perfluorophenol or nitrate; generally, X1And X2Independently Cl, Br, I or F; in general, X1And X2Independently is Cl;

R3is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl orSubstituted heteroatom-containing hydrocarbyl; in general, R3Is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl, C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R3Is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-di-isopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl or 2-methyl-phenyl;

R11、R12、R13and R14Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R11、R12、R13And R14Independently hydrogen, unsubstituted C1-C12Alkyl, substituted C1-C12Alkyl, unsubstituted C4-C12Cycloalkyl, substituted C4-C12Cycloalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Heteroaralkyl or substituted C6-C24Heteroaromatic compoundsAn alkyl group; in general, R11And R12Independently is methyl, and R13And R14Independently is hydrogen;

R3Ais hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R3AIs unsubstituted C1-C12Alkyl, substituted C1-C12Alkyl, unsubstituted C4-C12Cycloalkyl, substituted C4-C12Cycloalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Heteroaralkyl or substituted C6-C24A heteroaralkyl group; in general, R3AIs methyl, ethyl, n-propyl or phenyl; or R3ATogether with R4May form, together with the carbon atom to which they are attached, a five-to ten-membered cycloalkyl or heterocyclic ring; and

R4is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R4Is unsubstituted C1-C12Alkyl, substituted C1-C12Alkyl, unsubstituted C4-C12Cycloalkyl, substituted C4-C12Cycloalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Heteroaralkyl or substituted C6-C24A heteroaralkyl group; in general, R4Is methyl, ethyl, n-propyl or phenyl.

Olefin metathesis catalysis represented by the structure of formula (7)Non-limiting examples of agents are described in Table (3), where X1Is Cl, X2Is Cl, R11Is methyl, R12Is methyl, R13Is hydrogen, and R14Is hydrogen.

Table (3): an olefin metathesis catalyst of formula (7)

Figure BDA0002629549340000351

Figure BDA0002629549340000361

Wherein EMP is

When L is1A CAAC ligand of the formula:

Figure BDA0002629549340000392

m is 0 and M is ruthenium, the olefin metathesis catalyst of formula (1) is represented by the structure of formula (7A)

Wherein X1、X2、R1、R2、RaAnd RbAs defined herein;

x is-CR1aR2a-;

a is 1 or 2;

R1ais H, optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, halogen, optionally substituted C5-C24Aryl, optionally substituted C6-C24Aralkyl, optionally substituted C1-C20Heteroalkyl, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Or together with R2aForm, together with the carbon atom to which they are attached, an optionally substituted spiromonocyclic or spiropolycyclic C3-10Cycloalkyl or spiroheterocycle, or together with R3Or together with R4Forming an optionally substituted polycyclic ring;

R2ais H, optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, halogen, optionally substituted C5-C24Aryl, optionally substituted C6-C24Aralkyl, optionally substituted C1-C20Heteroalkyl, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Or together with R1aForm a spiro monocyclic or spiro polycyclic C with the carbon atom to which they are attached3-10Cycloalkyl or spiroheterocycle, or together with R3Or together with R4Forming an optionally substituted polycyclic ring;

y is-CR1bR2b-;

b is 0, 1 or 2;

R1bis H, optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, halogen, optionally substituted C5-C24Aryl, optionally substituted C6-C24Aralkyl, optionally substituted C1-C20Heteroalkyl, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Or together with R2bForm a five-, six-or ten-membered cycloalkyl or heterocycle with the carbon atom to which they are attached;

R2bis H, optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, halogen, optionally substituted C5-C24Aryl, optionally substituted C6-C24Aralkyl, optionally substituted C1-C20Heteroalkyl, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Or together with R1bForm a five-, six-or ten-membered cycloalkyl or heterocycle with the carbon atom to which they are attached;

R3ais H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substituted C3-8Cycloalkenyl, or together with R1aOr together with R2aOptionally substituted polycyclic rings may be formed, or together with R3aOptionally substituted spiromonocyclic or spiropolycyclic C may be formed3-10A cycloalkyl group;

R3bis H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substituted C3-8Cycloalkenyl, or together with R1aOr together with R2aOptionally substituted polycyclic rings may be formed, or together with R3Optionally substituted spiromonocyclic or spiropolycyclic C may be formed3-10A cycloalkyl group;

R4ais H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substituted C3-8Cycloalkenyl, or together with R1aOr together with R2aOptionally substituted polycyclic rings may be formed, or together with R4aOptionally substituted spiromonocyclic or spiropolycyclic C may be formed3-10A cycloalkyl group;

R4bis H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substituted C3-8Cycloalkenyl, or together with R1aOr together with R2aOptionally substituted polycyclic rings may be formed, or together with R4Optionally substituted spiromonocyclic or spiropolycyclic C may be formed3-10A cycloalkyl group;

R5is H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substitutedC of (A)3-8Cycloalkenyl, or together with R6Optionally substituted polycyclic rings may be formed;

R6is H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substituted C3-8Cycloalkenyl, or together with R5Or together with R7Optionally substituted polycyclic rings may be formed;

R7is H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substituted C3-8Cycloalkenyl, or together with R6Or together with R8Optionally substituted polycyclic rings may be formed;

R8is H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substituted C3-8Cycloalkenyl, or together with R7Or together with R9Optionally substituted polycyclic rings may be formed;

R9is H, optionally substituted C1-24Alkyl, halogen, -C (O) R21、-OR22、CN、-NR23R24、NO2、-CF3、-S(O)xR25、-P(O)(OH)2、-OP(O)(OH)2、-SR27Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl, optionally substituted C3-8Cycloalkenyl, or together with R8Can form multiple rings;

R21is OH, OR26、NR23R24Optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24Aryl or optionally substituted C3-8A cycloalkenyl group;

R22is H, optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24Aryl or optionally substituted C3-8A cycloalkenyl group;

R23is H, optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24Aryl or optionally substituted C3-8A cycloalkenyl group;

R24is H, optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24Aryl or optionally substituted C3-8A cycloalkenyl group;

R25is H, optionally substituted C1-24Alkyl, OR22、-NR23R24Optionally substituted heterocycle, optionally substituted C3-10Cycloalkyl, optionally substituted C5-24Aryl or optionally substituted C3-8A cycloalkenyl group;

R26is optionally substituted C1-24Alkyl, optionally substituted C3-10Cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24Aryl or optionally substituted C3-8A cycloalkenyl group;

R27is H, optionally substituted C1-24Alkyl, optionallySubstituted C3-10Cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24Aryl or optionally substituted C3-8A cycloalkenyl group;

x is 1 or 2; and with the proviso that

a. When a is 2, the "X-X" bond may be saturated or unsaturated;

b. when b is 2, the "Y-Y" bond may be saturated or unsaturated;

c. when a is 2 and the "X-X" bond is unsaturated, R2aIs absent;

d. when b is 1, R3aAnd R4aAre not present;

e. when b is 2, R3aAnd R4aAre not present; and

f. when b is 2 and the "Y-Y" bond is unsaturated, R2bIs absent.

CAAC ligands according to the values of a, b, X and YThe moiety (A) of (A) is represented by a structure selected from Table (4).

Table (4): structure of part (A) of CAAC ligand

Figure BDA0002629549340000432

Figure BDA0002629549340000441

Wherein: r1、R2、Ra、Rb、R3a、R3b、R4a、R4b、R5、R6、R7、R8、R9、R1a、R1b、X1、X2X and Y are as defined herein.

The nomenclature of the structure of formula (7A) is determined by the part (a) structure selected from table (4). For example, due to the presence of the moiety (a2) in the CAAC ligand, the following structure is designated formula (7a 2).

Figure BDA0002629549340000442

Table (5): an olefin metathesis catalyst of formula (7A)

Wherein: r1、R2、Ra、Rb、R3a、R3b、R4a、R4b、R5、R6、R7、R8、R9、R1a、R1b、X1、X2X and Y are as defined herein.

When L is1Is composed ofAn N-heterocyclic carbene ligand of the formula, and

Figure BDA0002629549340000462

is composed of

Figure BDA0002629549340000463

And X3And X4Independently S, and M is ruthenium, the olefin metathesis catalyst of formula (2) is represented by the structure of formula (8)

Wherein:

Rais unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RaIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl orA phenyl group;

Rbis unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RbIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or RaAnd RbLinked together to form a five or six membered heterocyclic ring having a sulfoxide group;

R3is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl, C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R3Is adamantyl, 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 2, 6-difluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl or 2-methyl-phenyl;

R4is unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl, C substituted by up to three substituents selected from5-C24Aryl: unsubstituted C1-C20Alkyl, substituted C1-C20Alkyl, unsubstituted C1-C20Heteroalkyl, substituted C1-C20Heteroalkyl, unsubstituted C5-C24Aryl, substituted C5-C24Aryl, unsubstituted C5-C24Heteroaryl, substituted C5-C24Heteroaryl, unsubstituted C6-C24Aralkyl, substituted C6-C24Aralkyl, unsubstituted C6-C24Alkylaryl, substituted C6-C24Alkaryl and halide groups; in general, R4Is 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 2, 6-difluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl or 2-methyl-phenyl;

R1is hydrogen, and R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene group;

R11、R12、R13and R14Independently is C1-C6Alkyl or hydrogen; in general, R11Is hydrogen or methyl, R12Is hydrogen or methyl, R13Is hydrogen, and R14Is hydrogen; in general, R11、R12、R13And R14Independently is hydrogen; and

Rx、Ry、Rwand RzIndependently is C1-C6Alkyl, hydrogen, halogen, unsubstituted phenyl or substituted phenyl; in general, RxIs methyl, hydrogen or Cl, RyIs hydrogen, RwIs hydrogen, RzIs Cl, tert-butyl, hydrogen or phenyl; or RxAnd RyLinked together to form an unsubstituted bicyclic or polycyclic aryl group or a substituted bicyclic or polycyclic aryl group(ii) a Or RwAnd RzLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or RyAnd RwLinked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.

Non-limiting examples of olefin metathesis catalysts represented by the structure of formula (8) are described in Table (6), where RaIs methyl, RbIs methyl, R11Is hydrogen, R12Is hydrogen, R13Is hydrogen, R14Is hydrogen, RyIs hydrogen, and RwIs hydrogen.

Table (6): an olefin metathesis catalyst of formula (8)

Figure BDA0002629549340000481

Non-limiting examples of catalysts useful in the present invention are represented by the following structures:

when L is1Is a CAAC ligand, andis composed ofAnd X3And X4Independently S, and M is ruthenium, the olefin metathesis catalyst of formula (2) is represented by the structure of formula (8A)

Figure BDA0002629549340000543

Wherein: r1、R2、Ra、Rb、R3a、R3b、R4a、R4b、R5、R6、R7、R8、R9、Rx、Ry、Rz、RwX, Y, a and b are as defined herein.

The nomenclature of the structure of formula (8A) is determined by the part (a) structure selected from table (4). For example, due to the presence of the moiety (a10) in the CAAC ligand, the following structure is designated formula (8a 10).

Watch (8A10)

Table (7): an olefin metathesis catalyst of formula (8A)

Figure BDA0002629549340000552

Wherein: r1、R1a、R1b、R2、Ra、Rb、R3a、R3b、R4a、R4b、R5、R6、R7、R8、R9、Rx、Ry、Rz、RwX, Y, a and b are as defined herein.

In other embodiments of the invention, the group 8 metal olefin metathesis catalysts of the invention are represented by the general structure of formula (9)

Wherein: m is a group 8 transition metal; typically, M is ruthenium or osmium; typically, M is ruthenium;

L1and L2Independently a neutral electron donor ligand;

n is 0 or 1; typically, n is 0;

m is 0, 1 or 2; typically, m is 0 or 1; typically, m is 0;

Raais unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RaaIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RaaIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl, benzyl or phenyl;

Rbbis unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RbbIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RbbIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl, benzyl or phenyl;

Raaand RbbCan be connected with themThe connected nitrogen atoms are connected to form a five-, six-or seven-membered heterocyclic ring;

Rccis unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RccIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RccIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl, benzyl or phenyl;

Rddis unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, RdIs unsubstituted C1-C10Alkyl, substituted C1-C10Alkyl, unsubstituted C3-C10Cycloalkyl, substituted C3-C10Cycloalkyl, unsubstituted C5-C24Aryl or substituted C5-C24An aryl group; in general, RddIs methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclohexyl, benzyl or phenyl;

Rccand RddMay be linked to the nitrogen atom to which they are linked to form a five-, six-or seven-membered heterocyclic ring;

Rbband RccMay be linked to the nitrogen atom to which they are attached to form a five-, six-or seven-membered heterocyclic ring;

X1and X2Independently, an anionic ligand; generally, X1And X2Independently halogen, trifluoroacetate, perfluorophenol or nitrate; in general, X1And X2Independently chlorine, bromine, iodine or fluorine;

R1and R2Independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl; in general, R1Is hydrogen, and R2Is unsubstituted phenyl, substituted phenyl, C1-C6Alkyl or substituted 1-propenyl; or R1And R2Linked together to form an optionally substituted indenylene.

In some embodiments of formula (9),

byRepresents; wherein: m, X1、X2、X3、X4、Rx、Ry、RwAnd RzAs defined herein.

In some embodiments of formula (9), L1Is composed of

Figure BDA0002629549340000591

Of the representation

Figure BDA0002629549340000592

Or L1Is composed ofA CAAC ligand represented; wherein Q1、Q2、p、q、R3a、R3b、R4a、R4b、R3、R4、R5、R6、R7、R8、R9、X5、Y5A and b are as defined herein.

When M is Ru, n is 0, M is 0 and L1Is a structure

Figure BDA0002629549340000594

The present invention provides a ligand of the formulaA catalyst represented by the formula (I) andbyWhen shown, the invention provides a structureCatalysts of the formulae

Wherein R is1、R2、R3、R4、Raa、Rbb、Rcc、Rdd、X1、X2、X3、X4、R11、R12、R13、R14、Rx、Ry、RwAnd RzAs defined herein.

When M is Ru, n is 0, M is 0 and L1In the case of CAAC ligands, the present invention provides catalysts represented by the structure of formula (10A)

Figure BDA0002629549340000611

Wherein: r1、R2、X1、X2、R3a、R3b、R4a、R4b、Raa、Rbb、Rcc、Rdd、R5、R6、R7、R8、R9X, Y, a and b are as defined herein.

The nomenclature of the structure of formula (10A) is determined by the part (A) structure selected from Table (4). For example, due to the presence of the moiety (a10) in the CAAC ligand, the following structure is designated formula (10a 10).

Table (8): an ene of the formula (10A)Hydrocarbon metathesis catalysts

Figure BDA0002629549340000622

Figure BDA0002629549340000631

Wherein: r1、R1a、R1b、R2、Ra、Rb、R3a、R3b、R4a、R4b、Raa、Rbb、Rcc、Rdd、R5、R6、R7、R8、R9、Rx、Ry、Rz、RwX, Y, a and b are as defined herein.

When M is Ru, n is 0, M is 0,

Figure BDA0002629549340000651

by

Figure BDA0002629549340000652

Is represented by X3And X4Is S, and L1When a ligand, the present invention provides a catalyst represented by the structure of formula (12A)

Figure BDA0002629549340000653

Wherein: r1、R2、R3a、R3b、R4a、R4b、Raa、Rbb、Rcc、Rdd、R5、R6、R7、R8、R9、Rx、Ry、Rw、RzX, Y, a and b are as defined herein.

The nomenclature of the structure of formula (12A) is determined by the part (A) structure selected from Table (4). For example, due to the presence of the moiety (a5) in the CAAC ligand, the following structure is designated formula (12a 5).

Figure BDA0002629549340000661

Table (9): an olefin metathesis catalyst of formula (12A)

Figure BDA0002629549340000662

Figure BDA0002629549340000671

Wherein: r1、R2、R1a、R1b、R3a、R3b、R4a、R4b、Raa、Rbb、Rcc、Rdd、R5、R6、R7、R8、R9、Rx、Ry、Rw、RzX, Y, a and b are as defined herein.

Non-limiting examples of catalysts useful in the present invention are represented by the following structures:

description of embodiments of macromolecular Compounds

In one embodiment, the ring-closing metathesis macrocycle product comprises a product internal olefin, wherein the product internal olefin is in the Z-configuration.

In some embodiments, the present invention provides methods of making compounds (i.e., products, olefin products; e.g., ring-closing metathesis products) having carbon-carbon double bonds (e.g., product internal olefins) with a Z: E ratio greater than 95:5, greater than 96:4, greater than 97:3, greater than 98:2, or in some cases greater than 99: 1. In some cases, about 100% of the carbon-carbon double bonds produced in the metathesis reaction may have the Z configuration. Z or cis selectivity may also be expressed as a percentage of the product formed (e.g., ring-closing metathesis product). In some cases, the product (e.g., ring-closing metathesis product) may be greater than 50% Z, greater than 60% Z, greater than 70% Z, greater than 80% Z, greater than 90% Z, greater than 95% Z, greater than 96% Z, greater than 97% Z, greater than about 98% Z, greater than 99% Z, or, in some cases, greater than 99.5% Z.

In one embodiment, the ring-closing metathesis reaction product has a carbon-carbon double bond of Z configuration and is represented by the structure of formula (a):

Figure BDA0002629549340000701

wherein:

q is 1,2, 3, or 4; and

p is 4,5, 6 or 7.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (a), where q is 2 and p is 4 or 6.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (a), where q is 1,2, 3, or 4, and p is 6 or 7.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (a), where q is 1 or 2, and p is 6.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (a), where q is 1,2, 3, or 4, and p is 7.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (a), where q is 1 and p is 6.

In another embodiment, the ring-closing metathesis reaction product has a carbon-carbon double bond of the Z configuration and is represented by the structure of formula (B):

Figure BDA0002629549340000711

wherein:

r is 1,2, 3 or 4; and

v is 4,5, 6 or 7.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (B), where r is 2 and v is 4 or 6.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (B), where r is 1,2, 3, or 4, and v is 6 or 7.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (B), where r is 1 or 2, and v is 6.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (B), where r is 1,2, 3, or 4, and v is 7.

In another embodiment, at least one ring-closing metathesis product is represented by the structure of formula (B), where r is 1 and v is 6.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by formula (E):

Figure BDA0002629549340000712

wherein:

Reis H, methyl, ethyl or propyl;

q is 1,2, 3, or 4;

p is 4,5, 6 or 7.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by formula (E), wherein ReIs methyl, q is 2, and p is 4 or 6.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by formula (E), wherein ReIs ethyl, q is 1,2, 3 or 4, and p is 6 or 7.

At one endIn one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by formula (E), wherein ReIs ethyl, q is 1 or 2, and p is 6.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by formula (E), wherein ReIs ethyl, q is 1,2, 3 or 4, and p is 7.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by formula (E), wherein ReIs ethyl, q is 1, and p is 6.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one olefin metathesis catalyst of formula (5) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing Z-olefinic moieties of formula (E) with at least one olefin metathesis catalyst of formula (6) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing Z-olefinic moieties of formula (E) with at least one olefin metathesis catalyst of formula (7) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one Z-stereoretentive olefin metathesis catalyst of formula (8) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one Z-stereoretentive olefin metathesis catalyst of formula (8A) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one Z-stereoretentive olefin metathesis catalyst of formula (9) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one Z-stereoretentive olefin metathesis catalyst of formula (10) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one Z-stereoretentive olefin metathesis catalyst of formula (10A) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one Z-stereoretentive olefin metathesis catalyst of formula (11) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one Z-stereoretentive olefin metathesis catalyst of formula (12) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In another embodiment, the present invention relates to a process for performing a ring-closing metathesis reaction, comprising: contacting a diene feedstock bearing a Z-alkene moiety of formula (E) with at least one Z-stereoretentive olefin metathesis catalyst of formula (12A) under conditions effective to promote the formation of at least one Z-macrocyclic product of formula (a) having a Z-configuration greater than 80% Z.

In one embodiment, the present invention provides a method of synthesizing a musk macrocyclic compound represented by formula (a), the method comprising ring-closing metathesis of a diene of formula (E) in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of formula (5), and wherein R ise、q、p、R1、R2、Ra、Rb、X1、X2、R3And R4As defined herein.

In one embodiment, the present invention provides a method of synthesizing a musk macrocyclic compound represented by formula (a), the method comprising ring-closing metathesis of a diene of formula (E) in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of formula (8), and wherein R ise、q、p、R1、R2、Ra、Rb、R11、R12、R13、R14、R3、R4、Rx、Ry、RzAnd RwAs defined herein.

In one embodiment, a Z-olefin moiety represented by formula (E) (wherein R iseIs a methyl group, q is 2, and p is 4 or 6) in the presence of a catalyst represented by the formula (8) wherein R is1Is hydrogen, R2Is phenyl, ethyl or together with R1Can form a phenylindenyl group, RaIs methyl, RbIs methyl, R11Is hydrogen, R12Is hydrogen, R13Is hydrogen, R14Is hydrogen, R3R is 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 2, 6-difluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl or 2-methyl-phenyl, R is4R is 2,4, 6-trimethylphenyl, 2, 6-diisopropylphenyl, 2-methyl-6-tert-butylphenyl, 2-isopropyl-6-methylphenyl, 2-isopropyl-phenyl, 2, 6-diethylphenyl, 2-ethyl-6-methylphenyl, 2,4, 6-trifluorophenyl, 2, 6-difluorophenyl, 3, 5-di-tert-butylphenyl, 2, 4-dimethylphenyl or 2-methyl-phenyl, R isxIs Cl, RyIs hydrogen, RzIs Cl, and RwIs hydrogen, to give a musk macrocyclic compound of formula (A) with a Z-configuration of more than 80% Z.

In one embodiment, the present invention provides a method for synthesizing a musk macrocyclic compound of formula (a) including ring-closing metathesis of a diene of formula (E) in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, where R iseIs H, methyl, ethyl or propyl; q is 1,2, 3, or 4; p is 4,5, 6, or 7; wherein the at least one metathesis catalyst is represented by the structure of formula (5), wherein the catalyst is selected from the group consisting of: c591, C731, C625, C763, C663, C641, C647m, C747, C647, C676, C773, C673, C651 and C831 m.

In one embodiment, the present invention provides a method for synthesizing a musk macrocyclic compound of formula (a) including ring-closing metathesis of a diene of formula (E) in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, where R iseIs H, methyl, ethyl or propyl; q is 1,2, 3, or 4; p is 4,5, 6, or 7; wherein the at least one metathesis catalyst is represented by the structure of formula (8), wherein the catalyst is selected from the group consisting of: c885ss, C785ss, C738ss, C869ss and C725 ss.

In one embodiment, the present invention provides a method of synthesizing a musk macrocycle of formula (B), the method comprisingRing-closing metathesis of a diene of formula (E) in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein ReIs H, methyl, ethyl or propyl; r is 1,2, 3 or 4; v is 4,5, 6 or 7; wherein the at least one metathesis catalyst is represented by the structure of formula (12), wherein the catalyst is selected from the group consisting of: c801TU、C701TU、C885TU、C881TU、C799TU、C951TUAnd C799uTU

In one embodiment, the present invention provides a method of synthesizing dilactones, such as vinyl tridecanoate (x ═ 9) and vinyl undecanedioate (x ═ 7) used in perfumes, wherein the starting materials are obtainable by a cross metathesis reaction in the presence of at least one metal olefin metathesis catalyst of the present invention. The olefin is further reduced and cyclized using known methods.

Figure BDA0002629549340000751

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by formula (F):

wherein:

Rfis H, methyl, ethyl or propyl;

r is 1,2, 3 or 4;

v is 4,5, 6 or 7.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by the formula (F), wherein RfIs methyl, r is 2, and v is 4 or 6.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by the formula (F), wherein RfIs ethyl, r is 1,2, 3 or 4, and v is 6 or 7.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by formula (F), whichIn RfIs ethyl, r is 1 or 2, and v is 6.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by the formula (F), wherein RfIs ethyl, r is 1,2, 3 or 4, and v is 7.

In one embodiment, the diene feedstock bearing Z-olefin moieties may be represented by the formula (F), wherein RfIs ethyl, r is 1, and v is 6.

In one embodiment, the present invention provides a method for synthesizing a musk macrocyclic compound of formula (B) comprising ring-closing metathesis of a diene of formula (F) wherein R is ring-closing metathesis in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis productfIs H, methyl, ethyl or propyl; r is 1,2, 3 or 4; v is 4,5, 6 or 7; wherein the at least one metathesis catalyst is represented by the structure of formula (5), wherein the catalyst is selected from the group consisting of: c591, C731, C625, C763, C663, C641, C647m, C747, C647, C676, C773, C673, C651 and C831 m.

In one embodiment, the present invention provides a method for synthesizing a musk macrocyclic compound of formula (B) comprising ring-closing metathesis of a diene of formula (F) wherein R is ring-closing metathesis in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis productfIs H, methyl, ethyl or propyl; r is 1,2, 3 or 4; v is 4,5, 6 or 7; wherein the at least one metathesis catalyst is represented by the structure of formula (8), wherein the catalyst is selected from the group consisting of: c885ss, C785ss, C738ss, C869ss and C725 ss.

In one embodiment, the present invention provides a method of synthesizing a musk macrocycle represented by formula (K)

The method comprises the following steps:

a) under conditions sufficient to form a metathesis product represented by the structure of formula (J),

Figure BDA0002629549340000771

in the presence of at least one olefin metathesis catalyst of formula (4), formula (5), formula (6) or formula (7), an olefin represented by formula (G)

Contacting with at least one metathesis reaction participant represented by formula (H):

Figure BDA0002629549340000773

wherein R is1mIs H or methyl; OR (OR)2mIs a protected hydroxyl group, which may be selected from alkyl ether groups; an ester group; a silyl ether group; or a carbonate group; r3mC being branched or straight chain1-C5An alkyl group; x is 2, 3,4 or 5; and y is 5, 6, 7 or 8.

In one embodiment, the present invention provides a method of synthesizing a musk macrocycle represented by formula (K)

Figure BDA0002629549340000774

The method comprises the following steps:

a) under conditions sufficient to form a metathesis product represented by the structure of formula (J),

in the presence of at least one olefin metathesis catalyst of formula (8), formula (8A), formula (9), formula (10A), formula (11), formula (12A) or formula (13), an olefin represented by formula (G)

Figure BDA0002629549340000782

Contacting with at least one metathesis reaction participant represented by formula (H):

wherein R is1mIs H or methyl; OR (OR)2mIs a protected hydroxyl group, which may be selected from alkyl ether groups; an ester group; a silyl ether group; or a carbonate group; r3mC being branched or straight chain1-C5An alkyl group; x is 2, 3,4 or 5; and y is 5, 6, 7 or 8.

In one embodiment of the invention, one or both of the first olefin and the second olefin may be an olefin having a terminal double bond.

In one embodiment of the invention, one of the first olefin or the second olefin may be represented by formula (G), wherein: r1mIs H or methyl; OR (OR)2mIs a protected hydroxyl group, which may be selected from alkyl ether groups; an ester group; a silyl ether group; or a carbonate group; and x is 2, 3,4 or 5.

In one embodiment of the invention, one of the first olefin or the second olefin may be represented by formula (H), wherein: r3mC being branched or straight chain1-C5An alkyl group; and y is 5, 6, 7 or 8.

In one embodiment of the present invention, the intermediate formed during the cross-metathesis reaction between the first olefin of formula (G) and the second olefin of formula (H) in the presence of at least one ruthenium olefin metathesis catalyst can be represented by formula (J), wherein: r1mIs H or methyl; OR (OR)2mIs a protected hydroxyl group selected from the group consisting of alkyl ether groups, ester groups, silyl ether groups, and carbonate groups; r3mC being branched or straight chain1-C5An alkyl group; x is 2, 3,4 or 5; r3mC being branched or straight chain1-C5An alkyl group; and y is 5, 6, 7 or 8.

TABLE (10) macrocyclic Compounds of the musks

Name (R) y x
E/Z Musk lactones 7 6
7-Musk lactone 5 8
Cyclopentadecenolide 9 3
9-hexadecene-16-lactide 7 5

The intermediate of formula (J) may be formed in the presence of any one of the ruthenium metathesis catalysts represented by formula (1), formula (2), formula (3), formula (4), formula (5), formula (6), formula (7), formula (8A), formula (9), formula (10A), formula (11), formula (12A), or formula (13). The ruthenium catalyst can be selected from any of the structures defined, represented, or exemplified herein.

Macrocyclic products

Common macrocyclic musk compounds include musk lactones (9-and 7-musk lactones), norvalactone (nirvanolide), cyclopentadecenolide, melodiole musk, musk ketene, cyclohexadecetone (velvione), civetone and cyclohexadecetone (globanone).

For example, the first olefinic compound and the second olefinic compound useful in forming 7-musk lactone may be selected from the group consisting of 10- (tert-butoxy) dec-1-ene and oct-7-enoic acid methyl ester or dec-9-en-1-yl acetate and oct-7-enoic acid methyl ester. The first olefinic compound and the second olefinic compound that can be used to form cyclopentadecenolide can be selected from trimethyl (pent-4-en-1-yloxy) silane and ethyl dodecyl-11-enoate. The first olefinic compound and the second olefinic compound useful in forming norvalactone can be selected from 4-methyl-6- (t-butoxy) hex-1-ene and methyl 9-decenoate, or 4-methyl 1-6- (t-butoxy) hex-1-ene and ethyl 9-decenoate, or 3-methylhex-5-en-1-yl propionate and methyl 9-decenoate.

Thus, the process of the present invention, in which a heterodimer is first formed by metathesis and then ring closure is carried out by a macrocyclization step, represents a simpler and cheaper process than RCM in forming macrocyclic musk compounds which can be industrially expanded in an economical manner.

As mentioned above, a variety of macrocyclic derivatives obtained via the process of the invention are useful in the fragrance and fragrance industry. Macrocyclic derivatives include, for example, the compounds listed in table (11).

TABLE (11) macrocyclic products

Figure BDA0002629549340000811

Experiment of

General information-material and method

Exemplary embodiments provided in accordance with the presently disclosed subject matter include, but are not limited to, the claims and the following embodiments.

All operations were carried out in the absence of air, filled with N, unless otherwise indicated2In a vacuum atmosphere glove box. Typically the solvent is purified by passing through a solvent purification column. Commercially available substrates were used as received. All solvents and substrates were sparged with Ar and then introduced into a glove box and filtered on neutral alumina (Brokmann I) prior to use. The olefin metathesis catalysts used in the following examples were synthesized according to the procedures described in international patent applications PCT/US2017/046283 and PCT/US 2018/027098.

Kinetic NMR experiments were performed on a Varian 600MHz spectrometer with an AutoX probe. Spectra were analyzed using mestrenova version 8.1.2.1H and13c NMR characterization data were obtained on a Bruker400 with Prodigy broadband cryoprobe and referenced to residual protic solvent.

All reactions involving the metal complexes were carried out in oven-dried glassware under an argon or nitrogen atmosphere using standard Schlenk techniques. Chemicals and solvents were obtained from Sigma Aldrich (Sigma-Aldrich), Strem, Alfa Aesar (Alfa Aesar), na-neoplastification (Nexeo), brentag (brentag), AG Layne and TCI. Commercially available reagents were used as received unless otherwise indicated. Silica gel was purchased from Fisher (0.040 μm-0.063 μm, EMD micropore).

The following abbreviations are used in the examples:

mL of

L liter

DEG C

CD2Cl2Deuterated dichloromethane

CDCl3Deuterated chloroform

C6D6Deuterated benzene

Ar argon gas

HCl hydrochloric acid

KHMDS potassium bis (trimethylsilyl) amide

r.t. room temperature

THF tetrahydrofuran

NaHCO3Sodium bicarbonate

Et2O diethyl ether

HCl hydrochloric acid

MgSO4Magnesium sulfate

DCM dichloromethane

90页详细技术资料下载
上一篇:一种医用注射器针头装配设备
下一篇:具有除草活性的马来酰亚胺衍生物、其农用组合物及其用途

网友询问留言

已有0条留言

还没有人留言评论。精彩留言会获得点赞!

精彩留言,会给你点赞!